The association between 1-year changes in albuminuria and subsequent risk of cardiovascular and renal events.
Read More »Impact of Sotagliflozin Added to Insulin
What is the impact of adjunctive sotagliflozin to insulin therapy on diabetes distress and treatment satisfaction in patients with type 1 diabetes?
Read More »Can Intermittent Fasting Help Patients Live with Diabetes?
Studies are showing that intermittent fasting may help patients better manage their diabetes and reduce their insulin intake.
Read More »Diabetes, Depression, and Dementia Link
The diagnosis and treatment of depression in the elderly population with type 2 diabetes are essential for managing dementia risks.
Read More »Prevention and Delay of Type 1 Diabetes
Does sustained elevated BMI accelerate the progression of islet autoimmunity in people not yet diagnosed with diabetes?
Read More »DKA Leads to Changes in Children’s Cognitive Function
Just one incident of DKA could potentially damage memory in children with type 1 diabetes.
Read More »Common Diabetes Medication as Treatment for Parkinson’s Disease
Findings show Parkinson’s disease risk is reduced in patients with type 2 diabetes mellitus (T2DM) after treatment with exenatide.
Read More »Ethnicity Can Affect Risk for Diabetes Complications
A diabetes patient’s risk for chronic kidney disease or cardiovascular disease can be impacted by various factors, including ethnic background.
Read More »Intermittent vs. Continuous Energy Restriction for Weight Loss and Metabolic Improvement
Just one lifestyle modification can go a long way.
Read More »Empagliflozin Benefit in Heart Failure, With or Without Diabetes
Studies of empagliflozin and dapagliflozin have shown to reduce cardiovascular risk, indicating a class effect for heart failure patients.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.